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Abstract
Introduction:  The  use  of  ultrasound  in  regional  anesthesia  allows  reducing  the  dose  of  local
anesthetic used  for  peripheral  nerve  block.  The  present  study  was  performed  to  determine  the
minimum effective  concentration  (MEC90)  of  bupivacaine  for  axillary  brachial  plexus  block.
Methods:  Patients  undergoing  hand  surgery  were  recruited.  To  estimate  the  MEC90,  a  sequen-
tial up-down  biased  coin  method  of  allocation  was  used.  The  bupivacaine  dose  was  5  mL  for
each nerve  (radial,  ulnar,  median,  and  musculocutaneous).  The  initial  concentration  was  0.35%.
This concentration  was  changed  by  0.05%  depending  on  the  previous  block;  a  blockade  failure
resulted in  increased  concentration  for  the  next  patient;  in  case  of  success,  the  next  patient
could receive  or  reduction  (0.1  probability)  or  the  same  concentration  (0.9  probability).  Sur-
gical anesthesia  was  deﬁned  as  driving  force  ≤2  according  to  the  modiﬁed  Bromage  scale,
lack of  thermal  sensitivity  and  response  to  pinprick.  Postoperative  analgesia  was  assessed  in
the recovery  room  with  numeric  pain  scale  and  the  amount  of  drugs  used  within  4  h  after  the
blockade.
Results: MEC90  was  0.241%  [R2:  0.978,  conﬁdence  interval:  0.20--0.34%].  No  patient,  with
successful  block,  reported  pain  after  4  h.
Conclusion:  This  study  demonstrated  that  ultrasound  guided  axillary  brachial  plexus  block  can
be performed  with  the  use  of  low  concentration  of  local  anesthetics,  increasing  the  safety
of the  procedure.  Further  studies  should  be  conducted  to  assess  blockade  duration  at  low
concentrations.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved. Ethical Institution Comittee Register: 0482/11.
ClinicalTrials.gov Register: NCT01838928.
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0104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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Concentrac¸ão mínima  efetiva  de  bupivacaína  para  o  bloqueio  do  plexo  braquial  via
axilar  guiado  por  ultrassom
Resumo
Introduc¸ão:  O  uso  do  ultrassom  na  anestesia  regional  permite  a  reduc¸ão  da  dose  de  anestésico
local utilizada  para  o  bloqueio  de  nervos  periféricos.  O  presente  estudo  foi  conduzido  com  o
objetivo de  determinar  a  concentrac¸ão  mínima  efetiva  (CME90)  de  bupivacaína  para  o  bloqueio
do plexo  braquial  via  axilar  (BPVA).
Métodos:  Pacientes  submetidos  a  cirurgias  da  mão  foram  recrutados.  Foi  usado  um  método  de
alocac¸ão ‘‘biased  coin’’  seqüencial  ‘‘up-down’’  para  estimar  a  CME90.  A  dose  de  bupivacaína
foi de  5  mL  para  cada  nervo  (radial,  ulnar,  mediano  e  musculocutâneo).  A  concentrac¸ão  inicial
de era  0,35%.  Essa  concentrac¸ão  era  alterada  em  0,05%  dependendo  do  bloqueio  anterior:  a
falha do  bloqueio  resultava  em  aumento  da  concentrac¸ão  para  o  próximo  paciente;  no  caso
de sucesso,  o  próximo  paciente  poderia  receber  ou  reduc¸ão  (probabilidade  de  0,1)  ou  mesma
concentrac¸ão (probabilidade  0,9).  A  anestesia  cirúrgica  foi  deﬁnida  como  forc¸a motora  ≤  2
segundo a  escala  de  Bromage  modiﬁcada,  ausência  de  sensibilidade  térmica  e  de  resposta  ao
pinprick. A  analgesia  pós-operatória  foi  veriﬁcada  na  sala  de  recuperac¸ão  anestésica  com  escala
numérica  de  dor  e  a  quantidade  de  analgésicos  utilizados  até  4  horas  após  o  bloqueio.
Resultados:  A  CME90  foi  de  0,241%  [R2:  0,978,  Intervalo  de  Conﬁanc¸a:  0,20%--0,34%].  Além
disso, nenhum  paciente  com  sucesso  do  bloqueio  apresentou  dor  após  4  horas.
Conclusão:  Este  estudo  demonstrou  que  pode-se  realizar  o  BPVA  guiado  por  ultrassom
utilizando-se  baixas  concentrac¸ões  de  anestésico  local,  aumentando  a  seguranc¸a do  proced-
imento. Novos  estudos  devem  ser  realizados  para  avaliar  a  durac¸ão  de  bloqueios  com  baixas
concentrac¸ões.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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introduction
 successful  peripheral  nerve  block  depends  on  the  cor-
ect  identiﬁcation  of  nervous  structures  and  the  injection
f  a  suitable  dose  of  local  anesthetic  around  it  in  order  to
btain  a  complete  impregnation  of  all  the  nerves  involved  in
he  surgery.  For  axillary  brachial  plexus  blockade  (ABPB),  in
hich  the  failures  are  typically  attributed  to  improper  nee-
le  placement  or  septation  of  the  brachial  plexus  sheath
n  axillary  region,1,2 volumes  up  to  80  mL  have  been  used
o  increase  the  success  rate.3 However,  the  use  of  large
mounts  of  local  anesthetic  increases  the  chance  of  sys-
emic  toxicity,  which  is  the  major  complication  of  regional
nesthesia.  Although  the  incidence  of  systemic  toxicity  is
ess  than  0.2%,  this  complication  is  difﬁcult  to  treat  and
otentially  fatal.4,5
The  introduction  of  ultrasound  into  clinical  practice  of
egional  anesthesia  made  it  possible  to  visualize  the  nerve
tructures,  allowing  greater  accuracy  in  the  administra-
ion  of  local  anesthetics.  The  minimum  effective  volume
f  local  anesthetic  for  blocking  some  peripheral  nerves  had
een  investigated,  and  studies  have  shown  that  effective
lockades  may  be  achieved  with  small  volumes  of  anes-
hetic,  which  reduces  the  likelihood  of  systemic  toxicity.6--11
owever,  the  clinical  applicability  of  low  volumes  and  the
imitation  of  identifying  intraneural  injections  by  ultrasound
ave  been  questioned.12
Reducing  the  local  anesthetic  concentration  may  limit
he  total  dose  administered  without  changing  the  volume
p
n
a
onjected.  However,  the  minimum  concentration  of  local
nesthetic  to  obtain  a  safe  ABPB  without  compromising  the
lockade  quality  and  effectiveness  has  not  been  established
et.
The  aim  of  this  study  was  to  calculate  the  mini-
um  effective  concentration  of  20  mL  bupivacaine  without
pinephrine,  which  reached  surgical  anesthesia  dose  for
xillary  brachial  plexus  block  guided  by  ultrasound  for  hand
urgery  in  90%  of  patients  (MEC90).
aterial and methods
he  present  study  used  a  step-up/step-down  model  to  deter-
ine  the  MEC90  of  bupivacaine  in  ultrasound  guided  ABPB.
This  protocol  was  approved  by  the  Ethics  Research  Com-
ittee  of  our  institution  (Ref  0482/11)  and  registered  in  the
linical-Trials.gov  (protocol  NCT01838928).  Patients  aged
etween  18  and  65  years,  with  indication  for  anesthesia  and
nalgesia  brachial  plexus  block,  undergoing  elective  surgery
f  the  hand  with  less  than  2  h  duration,  physical  status  ASA
,  II  or  III  according  to  the  American  Society  of  Anesthesiol-
gists,  and  body  mass  index  (BMI)  <35  kg  m−2 were  included
n  the  study  between  the  years  2011  and  2012,  after  sign-
ng  the  informed  consent  form.  Patients  with  disorders  that
revented  the  assessment  of  motor  sensitive  function,  cog-
itive  impairment  or  active  psychiatric  condition,  infection
t  the  blockade  puncture  site,  bleeding  disorders  or  history
f  allergy  to  bupivacaine  were  excluded  from  the  study.
Minimum  effective  concentration  of  bupivacaine  for  axillary  bra
Table  1  Modiﬁed  Bromage  scale.
Grade  Deﬁnition
4  Full  muscle  strength  in  relevant  muscle  groups
3 Reduced  strength,  but  able  to  move  against
resistance
2 Ability  to  move  against  gravity,  but  not  against
resistance
1 Discrete  movements  (trembling)  of  muscle
groups
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-0 Lack  of  movement
After  inclusion  in  the  study,  demographic  data  of  all
patients  were  recorded.  Then,  routine  monitoring  for  sur-
gical  procedure  was  performed  with  ECG,  noninvasive  blood
pressure,  and  pulse  oximetry.  Peripheral  venous  access  was
obtained  in  the  upper  limb  contralateral  to  the  surgery  for
infusion  of  crystalloid  solution  and  sedation  with  midazolam
(0.03  mg  kg−1).
Axillary  brachial  plexus  block  was  performed  with  the
ultrasound  M-Turbo® guidance  and  13--6  MHz  linear  trans-
ducer  (SonoSite,  Bothell,  WA,  USA)  and  a  peripheral  nerve
stimulator  Stimuplex® DIG  RC  (B.  Braun,  Melsung,  Germany)
with  the  patient  in  supine  position.  Skin  antisepsis  was  per-
formed  with  chlorhexidine;  transducer  was  protected  with
sterile  plastic;  and  puncture  site  was  inﬁltrated  with  1%
lidocaine  (2  mL).  After  the  brachial  plexus  nerves’  visual-
ization  by  ultrasound  the  puncture  was  performed  with  a
22  G  needle  for  electrostimulation  50  mm  AEQ  2250  (BMD
Group,  Venice,  Italy).  Neurostimulator  was  used  to  conﬁrm
the  identiﬁcation  of  the  four  nerves  (median,  ulnar,  radial,
musculocutaneous)  separately.  A  dose  of  5  mL  bupivacaine
without  epinephrine  was  slowly  injected  around  each  nerve
visualized  with  ultrasound,  completing  a  total  of  20  mL.  The
5  mL  dose  was  deﬁned  based  on  current  regional  anesthe-
sia  protocols  of  our  institution.  If  there  was  any  resistance
to  the  solution  injection,  the  patient  complained  of  severe
pain,  or  an  increase  in  nerve  diameter  was  visualized,  and
the  needle  was  repositioned.  The  local  anesthetic  dispersion
was  carefully  monitored  by  the  image  so  it  went  around  the
nerve  perimeter.
The  end  of  the  local  anesthetic  solution  injection  was
considered  the  time  zero  to  assess  the  blockade  effective-
ness.  An  anesthesiologist  who  was  not  present  during  the
injection  and  was  unaware  of  the  anesthetic  concentration
assessed  the  motor,  thermal,  and  sensory  blocks.  This  assess-
ment  occurred  every  5  min,  from  time  zero  until  the  block
was  considered  effective,  but  limited  to  30  min.  After  that
time,  if  the  block  was  not  appropriate,  a  complementation
was  performed.
Modiﬁed  Bromage  scale6,11 (Table  1)  was  used  to  assess
motor  function.  The  following  muscles  were  evaluated:  ﬁn-
ger  ﬂexors  (median  nerve),  ﬁnger  extensors  (radial  nerve),
ﬁnger  adductors  (ulnar  nerve)  and  elbow  ﬂexion  (musculo-
cutaneous  nerve).  The  score  was  obtained  for  each  of  the
four  nerves.
Thermal  sensation  was  assessed  with  gauze  and  alco-
hol  and  pain  sensitivity  with  the  pinprick  test  with  a  23  G
needle.  Both  assessments  were  performed  separately  for
each  nerve  and  sensation,  and  the  following  locations  were
c
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sed:  hypothenar  eminence  (ulnar  nerve),  thenar  eminence
median  nerve),  dorsum  of  hand  (radial  nerve),  and  lateral
spect  of  the  forearm  (musculocutaneous  nerve).
Latency  was  deﬁned  as  the  period  between  time  zero  and
he  time  that  surgical  anesthesia  was  obtained.
Surgical  anesthesia  was  considered  effective  if  motor
cale  was  less  than  or  equal  to  2,  if  there  was  no  feeling
f  pain  and  cold  for  all  nerves,  and  if  there  was  no  need
or  supplementation  (local  or  general  anesthesia)  during
urgery.  Patients  who  exhibited  any  degree  of  blockade  fail-
re  received  supplementation  with  nerve  local  anesthesia,
istal  to  the  axilla  and  guided  by  ultrasound,  or  conversion
o  general  anesthesia.
All  patients  received  subcutaneous  injection  of  2%  lido-
aine  with  epinephrine  (3  mL)  to  complement  the  intercostal
erve  block,  due  to  the  use  of  pneumatic  tourniquet  in  the
iddle  third  of  the  arm.  During  surgery,  propofol  infusion
25--40  mcg  kg−1 min−1) was  used  for  sedation  until  Ramsay
core  =  3.
After  surgery,  patients  were  admitted  to  the  post-
nesthesia  care  unit  and  remained  monitored  until  they
eached  the  conditions  of  discharge  as  outpatients.  While
emaining  in  the  PACU,  postoperative  analgesia  was  assessed
hrough  a  numerical  pain  scale  (0  =  no  pain  and  10  =  worst
ain  ever  experienced  by  the  patient)  and  the  total  anal-
esic  requested  by  the  patient  up  to  4  h  after  the  ABPB  was
uantiﬁed.
tatistical  analysis
n  this  study,  the  primary  objective  was  to  estimate  the  min-
mum  effective  concentration  of  a 5  mL  bupivacaine  solution
er  nerve  (total  of  20  mL)  for  axillary  brachial  plexus  block-
de  guided  by  ultrasound.  For  this,  an  allocation  method
f  biased  coin  up-down  sequence  was  used  to  estimate
he  MEC90.13 The  local  anesthetic  initial  concentration  was
.35%.  This  dose  was  chosen  based  on  the  clinical  experi-
nce  of  our  service  and  also  on  statistical  simulations  in
arious  doses.  Each  subsequent  dose  was  based  on  previ-
us  dose.  The  success  or  failure  of  the  ABPB  determined  the
ecrease  or  increase  of  local  anesthetic  concentration  for
he  next  patient,  respectively.  After  an  effective  block,  the
ext  patient  was  randomized  with  a  probability  of  0.1  to
eceive  the  next  lower  dose  and  randomized  with  a  proba-
ility  of  0.9  to  receive  the  same  dose.  These  probabilities
ere  calculated  as  follows:
Probability  for  dose  reduction  (P1):  P1  =  (desired
MEC  −  1)  ×  (desired  MEC)−1
Probability  for  dose  maintenance  (P2):  P1  =  1  −  P1
In  this  study,  we  chose  to  perform  the  calculation  to  esti-
ate  the  minimum  effective  concentration  in  90%  of  cases,
hus:
-  P1  =  (1  −  0.9)/0.9  =  ≈0.1
-  P2  =  1  −  P1  =  ≈0.9The  sequence  was  examined  using  logistic  regression  to
alculate  the  minimum  effective  concentration  for  90%  of
ases.
1 A.  Takeda  et  al.
f
n
(
p
s
r
m
d
q
a
f
C
d
I
U
R
F
a
r
e
2
l
[
0
s
b
Table  2  Demographic  characteristics  of  patients.
Age  (years)a 35.5  (28--44.5)
Sex (M/F)  32/14
ASA
I 31  (67.4%)
II 15  (22.6%)
BMI (kg  m−2) 24.9  (22.5--26.8)
BMI, body mass index.
a Data presented as median (quartiles).
Table  3  Distribution  of  surgical  procedures  (n  =  46).
Metacarpal  fracture  17
Extensor  tendon  injury  6
Excision  of  bone  tumor  5
Flexor tendon  injury  5
Phalanx  pseudoarthrosis  3
Synovectomy  3
Dupuytren  3
Scaphoid  fracture  3
Synthesis  material  removal  1
a66  
For  sample  size  calculation,  simulations  were  per-
ormed  assuming  a  ﬁxed  biased  coin  model  and  a  minimum
umber  of  positive  responses.  A  signiﬁcance  level  of  5%
˛  =  0.05)  was  considered.  A  sample  size  of  at  least  46
atients  was  selected  after  testing  with  a  variety  of
ettings,  each  with  simulations  of  both  responses  and  cor-
esponding  doses  selected  by  the  sequential  allocation
ethod  described  above,  and  starting  with  various  initial
oses.
Nonparametric  data  are  presented  as  medians  and
uartiles  (P25--P75).  Categorical  data  are  presented  as
bsolute  and  relative  frequencies.  Calculations  were  per-
ormed  using  Microsoft  Excel  for  WindowsTM (Microsoft
orp.,  Redmond,  WA,  USA),  GraphPad  PrismTM for  Win-
ows  (GraphPad  Software  Inc.,  San  Diego,  CA,  USA),  and
BM  SPSS  StatisticsTM 20.0  for  Mac  (SPSS  Inc.,  Chicago,  IL,
SA).
esults
orty-six  patients  were  enrolled  and  their  demographic
nd  surgical  characteristics  are  shown  in  Tables  2  and  3,
espectively.  No  patient  who  met  the  inclusion  criteria  was
xcluded  from  the  study.
The  present  study  showed  that  the  MEC90  for  a  total  of
0  mL  solution  of  bupivacaine  without  epinephrine  for  axil-
ary  brachial  plexus  block  guided  by  ultrasound  was  0.241%
correlation  coefﬁcient  --  R2:  0.978;  conﬁdence  interval  (CI):
.20--0.34%].
According  to  the  results  shown  in  Fig.  1,  there  is  a
trong  positive  correlation  between  the  success  proba-
ility  and  observed  concentrations.  Fig.  2  illustrates  the
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Figure  1  Graphical  representation  of  the  upDuration,  min  (P25--P75) 55(40--78,  75)
a Data presented as median (quartiles).
orrelation  between  success  probability  and  observed  con-
entrations.
Considering  all  study  patients,  the  mean  latency
ime  was  15  (10--20)  min.  Considering  only  patients  who
s
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Figure  2  Correlation  between  concentration  and  success
probabilities.
Table  4  Latency  for  different  concentrations.
Dose  Number  of
blocks/successful
Latency  (min)a
(P25--P75)
0.15%  0/1  --
0.20% 11/13  25  (25--30)
0.25% 17/18  20  (15--22.15)
0.30% 13/13  15  (10--16.15)
0.35% 1/1  5
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ta Data presented as median (quartiles).
received  blockades  with  0.25%  concentration  (the  near-
est  MEC90  concentration),  the  mean  latency  time  was
20  (15--22.15)  min.  Mean  latency  times  for  each  assessed
concentration  are  summarized  in  Table  4.  Blockade  duration
was  not  determined  in  this  study.
There  was  100%  blockade  failure  with  the  use  of  0.15%
bupivacaine.  However,  all  blockades  performed  with  a
concentration  equal  to  or  greater  than  0.30  were  successful
(Fig.  1).
No  patient  included  in  the  protocol  showed  absence  of
speciﬁc  response  to  neurostimulator  or  intraoperative  pain.
All  patients  considered  as  failure  maintained  median  nerve
motor  function,  and  two  patients  also  maintained  radial
nerve  motor  function.  The  lack  of  thermal  sensitivity  was
also  observed  in  these  patients,  although  maintaining  the
motor  function.
Two  surgical  procedures  exceeded  the  expected  dura-
tion  of  surgery  and  lasted  more  than  120  min,  without
complications  for  the  patient  or  need  for  supplemental  anes-
thesia.
All  surgical  procedures  for  which  patients  received  suc-
cessful  blocks  were  performed  uneventfully,  and  there
was  no  need  for  local  and  systemic  anesthetic  supple-
mentation  Moreover,  all  patients  reported  no  pain  4  h
after  the  ABPB  (EAV  =  0).  There  were  no  complications,
such  as  vascular  puncture  or  local  anesthetic  intoxica-
tion,  during  the  study.  All  patients  were  discharged  on  the
same  day  of  the  surgery,  without  the  need  for  hospital
readmission.
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iscussion
eripheral  nerve  block  success  is  based  on  the  accuracy
ith  which  the  nerves  are  located  and  impregnated  by  the
nesthetic.  However,  other  important  factors  affecting  its
uccess  rate  and  quality  are  the  concentration  and  vol-
me  of  anesthetic  injected  near  the  nerves.14 The  use  of
ltrasound  has  introduced  a  new  perspective  on  regional
nesthesia.  This  technology  enables  a  real-time  visualiza-
ion  of  the  entire  procedure,  allowing  the  anesthesiologist
o  precisely  position  the  needle  around  the  structure  to
e  blockaded.  Thus,  ultrasound  enables  a  decrease  in  the
olume  or  concentration  used  during  the  blockade.  This
tudy  has  proved  it  possible  to  achieve  a  successful  axil-
ary  brachial  plexus  block  guided  by  ultrasound  with  low
oncentrations  of  local  anesthetic.
Adverse  events,  such  as  systemic  toxicity,  may  be
ose-dependent.  Therefore,  prevention  of  adverse  events
s  crucial  to  promote  patient  safety  during  regional
nesthesia.5 Some  guidelines  for  regional  anesthesia  include
ocal  anesthetic  dose  limitation  through  the  use  of  smaller
olumes  and  concentrations  during  blockade.  The  use  of
ow  doses  of  local  anesthetic  provides  a  safer  blockade
ith  less  risk  of  complications,  particularly  associated
ith  the  systemic  toxicity  of  these  anesthetics.  Despite
he  development  of  effective  techniques  for  treating  such
omplications,  such  as  the  use  of  lipid  solutions,15,16 the  use
f  low  doses  of  local  anesthetics  promotes  a  blockade  with
n  anesthetic  mass  of  a  wide  range  of  safety  relative  to  the
oxic  dose.
One  way  to  reduce  the  dose  of  local  anesthetic  is  by
ecreasing  the  volume  used  for  the  blockade.  In  a  pre-
ious  study  conducted  by  our  group,  the  axillary  brachial
lexus  blockade  was  successful  with  approximately  1.6  mL
f  0.5%  bupivacaine  with  epinephrine  1:200,000  per  nerve.11
’Donnel  and  Iohom  also  showed  similar  results  using  2%
idocaine.6 However,  the  use  of  low  volume  technique  is
robably  difﬁcult  to  reproduce  in  clinical  practice.  On  the
ther  hand,  the  present  study  used  a  volume  more  close  to
hat  used  in  clinical  practice,  probably  making  the  technique
asier  to  be  applied.
It  is  known  that  the  local  anesthetic  concentration  is
n  important  factor  inﬂuencing  the  latency  time  of  periph-
ral  nerve  block.  The  local  anesthetic  penetration  into  the
erve  root  is  affected  by  the  concentration  of  the  solution
sed.17 It  is  suggested  that  increasing  the  local  anesthetic
oncentration  around  the  nerve  increases  the  concentra-
ion  gradient  and  may  facilitate  the  diffusion  of  anesthetic
olecules  into  the  nerve,  and  thereby  reducing  the  nerve
lock  latency  time.  However,  in  the  present  study,  we  found
 median  latency  close  to  the  median  latency  obtained  in
ur  previous  study,  with  low  volumes.11 One  possible  expla-
ation  is  that,  despite  the  low  concentration,  the  total
ass  of  bupivacaine  used  in  this  study  was  greater  than
hat  used  in  the  study  with  low  volumes.  Furthermore,  a
tudy  comparing  different  concentrations  but  maintaining
he  anesthetic  mass  ﬁxed  in  ABPB  revealed  that  the  motor
atency,  but  not  the  sensory  latency,  was  smaller  when
sing  larger  volume  of  local  anesthetic.18 Thus,  this  is  not
 deﬁned  issue,  requiring  further  studies  to  elucidate  the
atter.
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The  use  of  lower  concentrations  of  local  anesthetic  may
ring  some  beneﬁts.  Pippa  et  al.  reported  that  the  use
f  high  concentrations  of  local  anesthetic  for  interscalene
rachial  plexus  block  is  associated  with  a  greater  num-
er  of  complications,  such  as  phrenic  nerve  paralysis  and
ypotension.19 Furthermore,  in  vitro  studies  have  shown
hat  the  use  of  local  anesthetics  is  associated  with  cytotoxic
ffects,  including  induction  of  apoptosis  in  Schwann  cells,
itochondrial  injury,  caspase  activation,  and  increased
ytoplasmic  calcium.  However,  all  these  effects  were
elated  to  the  time  of  exposure  and  higher  concentration
f  the  drug  used,  which  theoretically  suggests  greater  safety
hen  using  lower  concentrations  of  local  anesthetic.20 More-
ver,  the  use  of  lower  concentrations  may  decrease  the
ostoperative  motor  block  time,  which  may  be  more  com-
ortable  for  some  patients.21 Finally,  the  dose  required  to
roduce  a  successful  block  may  be  clinically  relevant  in  pedi-
tric  patients  or  when  the  combination  of  different  blocks  is
equired  for  the  surgery  due  to  the  potential  risk  of  systemic
oxicity.
This  study  has  some  limitations.  Initially,  we  do  not
easure  the  duration  of  ABPB  using  low  doses  of  bupiva-
aine.  The  use  of  low  doses  of  local  anesthetic  decreases
lock  duration,  deﬁned  as  the  time  between  the  end
f  the  blockade  onset  and  recovery  of  motor  and  sen-
ory  functions.22 As  it  was  not  known  how  the  use  of
ow  concentrations  would  inﬂuence  the  block  duration,  it
as  decided  to  include  procedures  planned  to  last  up  to
 h.
Furthermore,  this  study  was  not  designed  to  assess
he  minimum  effective  concentration  of  local  anes-
hetic  for  postoperative  analgesia,  and  further  studies
hould  be  performed  to  evaluate  this  topic.  However,  no
atient  with  successful  block  reported  pain  4  h  after  the
lockade.
We  also  know  that  the  results  were  limited  to  obtain  the
EC90  to  a  5 mL  solution  of  bupivacaine  for  each  ABPB  nerve,
nd  it  may  not  represent  the  same  concentration  for  smaller
olumes.  More  studies  should  be  conducted  to  evaluate  the
fﬁcacy  of  different  volumes  for  this  concentration.  Finally,
ne  should  not  extrapolate  this  result  to  other  peripheral
erve  blocks.
In  summary,  this  study  suggests  that  with  the  use
f  ultrasound  it  is  possible  to  obtain  surgical  anes-
hesia  with  concentrations  close  to  0.25%  bupivacaine
hen  using  5  mL  volume  of  anesthetic  for  each  brachial
lexus  nerve  (radial,  median,  ulnar,  and  musculocuta-
eous)  by  axillary  route,  decreasing  the  local  anesthetic
ose  used  and  increasing  the  procedure  safety.  More  stud-
es  should  be  conducted  to  determine  the  effects  that
ow  concentrations  of  bupivacaine  may  have  on  blockade
uration.
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